PSMA & Beyond Conference

The 2026 PSMA & Beyond Conference is just 3 days away! We're excited to bring together leading experts shaping the future of PSMA PET imaging, RLT, and theranostics. Don't miss out - register today! bit.ly/2026-psma-regi… Visit out website: psmaconference.ucsf.edu

Less than two weeks until the 2026 PSMA & Beyond Conference! Join us for an exciting program featuring an outstanding lineup of speakers! Can’t attend in person? Join virtually from anywhere. Register now: bit.ly/2026-psma-regi… @CalaisJeremie

Heading to the PSMA & Beyond Conference? Stay at the Luskin Conference Center Hotel, steps from all the action! Reserve your room at our discounted group rate before it’s too late! Visit our website: psmaconference.ucsf.edu/accommodations…

Can't travel to LA? No problem! Join the 2026 PSMA & Beyond Conference YOUR way! In-person at UCLA's Luskin Center (March 26-27) or live virtual access from anywhere. March 26-27, 2026: #PSMAConference #ProstateCancer #Theranostics

We’re excited to welcome @PChoyke from @theNCI to the 2026 PSMA & Beyond Conference! Dr. Choyke will explore the clinical impact of PSMA PET findings, and introduce the idea that not all PSMA avid disease impacts the outcome of patients.

Proud to share the 2025 PSMA Conference donated $8,500 to @ProjectHOPE to support LA wildfire relief—made possible by speakers who generously donated their honoraria. Grateful for this community and for the important work Project HOPE does. projecthope.org/news-stories/s…

Join for at the 2026 PSMA & Beyond Conference March 26-27, in Los Angeles or virtually! Don't miss this opportunity to learn from leading experts, explore the latest advances, and connect with innovators in the field. Register today! cvent.me/POP3gD

We're excited to welcome Owen Witte, MD (@UCLA ) as a keynote speaker at the 2026 PSMA & Beyond Conference! Dr. Witte will highlight how discoveries in basic science are shaping the future of prostate cancer therapies.

Thinking about alpha particles? Join us at the 2026 PSMA & Beyond Conference, where we are going to compare astatine and actinium. What are the differences and does dose rate matter?

Just a reminder—there’s one week left to submit abstracts for the PSMA & Beyond Conference. The deadline is January 12th. Don’t miss the opportunity to share your work!

Dr. Kevin Tabury of @SCKCEN brings radiation biology insights from spaceflight missions to help us understand tissue response in oncology. A truly unique perspective in this unique cross-disciplinary session!

One of the biggest questions in prostate cancer research is how to best leverage PSMA PET in clinical trials. Hear from Dr. Alicia Morgans as she explores how PSMA PET can be integrated as a clinical trial endpoint.

📢 Call for Abstracts — Deadline December 15! The 2026 PSMA & Beyond Conference invites researchers to submit abstracts showcasing innovative work in PSMA imaging and radioligand therapy. Don’t miss this opportunity to share your findings! 🌐Visit: psmaconference.ucsf.edu/poster-abstrac…

✨Registration is now open for 2026 PSMA & Beyond! We will explore the latest advances in PSMA-targeted imaging and therapy — and what lies beyond. 👉More info at: psmaconference.ucsf.edu 🎟Register today! cvent.me/8VX8qP

New in @ASCO DailyNews PSMA-PET for Therapy Response in Prostate Cancer Quantitative, whole-body imaging is here, but challenges remain: standardization, AI, & adoption. 🧠Insights from @CalaisJeremie, @UCLA 🔗dailynews.ascopubs.org/do/psma-pet-th… #Theranostics #NuclearMedicine @UCLAHealth

The origins and evelution of #PSMA! @radnucmp @UTSWMedCenter retraces PSMA's journey—from LNCaP & cDNA cloning to the breakthrough that NAALADase is PSMA. His work with Alan Kozikowski paved the way for PSMA-11 & PSMA-617, transforming care for #mCRPC patients. #WatchNow on UroToday > bit.ly/44CmJtT #ProstateCancer #NuclearMedicine @UCLA @PCFnews @UCSF @PSMAconference

Pre-chemo 177Lu-PSMA Trials: #PSMAfore, #SPLASH, and #ECLIPSE. Presentation by @EAntonarakis @UMNCancer comparing PSMA radioligand therapy trials in #mCRPC for the post-ARPI, pre-chemotherapy setting. #WatchNow on UroToday > bit.ly/45Oc5kj @PCFnews @PSMAconference #PSMAandBeyond2025

Sequencing with RLT in #mCRPC. Presentation by @TDorffOnc @cityofhope addressing treatment sequencing in advanced #ProstateCancer. She notes PARP inhibitors show superior efficacy when used early in BRCA2-altered patients. #WatchNow > bit.ly/4jOQY50 @PSMAconference #PSMAandBeyond2025 @PCFnews

Radiation safety and ecology: Comparison of Practices in the US and the World. 🚨 Radiation safety in theranostics isn't one-size-fits-all. , Catherine Meyer breaks down key infrastructure needs: 🛡️ Shielding (structural + operational) 🏥 Patient release (Germany vs. US/Aus) ♻️ Waste management (decay vs. dilution) #WatchNow > bit.ly/402kGMw @UCSF @UCLA @PSMAconference #PSMAandBeyond2025 @PCFnews

What's the role of Primary Score in #ProstateCancer diagnosis? @DrMHofman @PeterMacCC shares insights at #PSMAandBeyond2025! Watch to learn more about this innovative tool > bit.ly/4monaP3 @PSMAconference @PCFnews @UCLA @UCSF